These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2822893)

  • 1. Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardium.
    Boyd RA; Giacomini JC; Wong FM; Nelson WL; Giacomini KM
    J Pharmacol Exp Ther; 1987 Oct; 243(1):118-25. PubMed ID: 2822893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in the negative inotropic response of 1,4-dihydropyridine calcium channel blockers in myocardium.
    Boyd RA; Giacomini JC; Giacomini KM
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):650-7. PubMed ID: 2467082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
    Bolger GT; Marcus KA; Daly JW; Skolnick P
    J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel high affinity class of Ca2+ channel blockers.
    Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
    Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
    Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
    Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding properties of (+/-)[3H]benidipine hydrochloride to rat heart membranes.
    Ishii A; Toyama J
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):191-6. PubMed ID: 7679151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic and radioligand binding studies of 1,4-dihydropyridines in rat cardiac and vascular preparations: stereoselectivity and voltage dependence of antagonist and activator interactions.
    Zheng W; Stoltefuss J; Goldmann S; Triggle DJ
    Mol Pharmacol; 1992 Mar; 41(3):535-41. PubMed ID: 1372088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
    Janis RA; Sarmiento JG; Maurer SC; Bolger GT; Triggle DJ
    J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart.
    Goll A; Glossmann H; Mannhold R
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):303-12. PubMed ID: 3027587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective inhibition of thromboxane-induced coronary vasoconstriction by 1,4-dihydropyridine calcium channel antagonists.
    Eltze M; Boer R; Sanders KH; Boss H; Ulrich WR; Flockerzi D
    Chirality; 1990; 2(4):233-40. PubMed ID: 1964575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma.
    Haase H; Wallukat G; Vetter R; Will H
    Biomed Biochim Acta; 1987; 46(8-9):S363-9. PubMed ID: 2829862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.
    Schmid A; Romey G; Barhanin J; Lazdunski M
    Mol Pharmacol; 1989 Jun; 35(6):766-73. PubMed ID: 2543910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P; Ferry D; Lübbecke F; Glossmann H
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel.
    Triggle DJ; Janis RA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S949-55. PubMed ID: 6085383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.